FDA District Office meeting
This article was originally published in The Gray Sheet
Executive Summary
Scheduled for July 17 in New Orleans to discuss "good clinical practices in investigational product research." Topics to be discussed are requirements for conducting investigational research and "practical issues," including how to prepare for a data audit and what to expect during an investigation. The meeting is formatted for open dialogue between FDA and individuals involved in investigational product research. First priority for attendance will be given to individuals located in Louisiana and Mississippi. Call Rebecca Asente at 504/589-6344, ext. 158, for additional information...
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continue, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.